The physiological defects associated with 17 temperature-sensitive mutants of the KENYA 3/57 strain of foot-and-mouth disease virus were examined in terms of the ability of the mutants to produce infective RNA and complementfixing antigen under restrictive conditions. The yields of infective RNA obtained with different mutants ranged from less than o'3I to 87 ~ of normal, and of complement-fixing antigen from I2-6 to 99"6 % of normal.
INTRODUCTION
Temperature-sensitive (ts) mutants of foot-and-mouth disease virus (FMDV), induced by 5-fluorouracil treatment of a strain able to multiply at high temperature, have been used to demonstrate genetic recombination between single-step mutants of the same virus strain (Pringle, I968 ) . Complementation was also observed and found to parallel the pattern of recombination between mutants (unpublished observations). Experimental difficulties similar to those encountered with other mammalian picornaviruses (Cooper, 1967) prevented analysis of the mutants by complementation test. This paper describes experiments which attempt to define the functional defect associated with each ts mutant in terms of the ability of the mutant tO produce infective RNA and complement-fixing (CF) antigen under the restrictive conditions and to correlate this with the results of recombination experiments.
METHODS
Virus'. The derivation of the ts mutants of the KENYA 3/57 strain has been described (Pringle, I968) .
Cells. BHK-2I, clone I3 cells (Macpherson & Stoker, 1962) were used for propagation of mutants and for infectivity assays. Serum-free medium was used throughout.
Extraction and assay of infective RNA. Extraction of infective RNA by cold and hot phenol methods was tried initially, but an acid buffer method described by Arlinghaus, Polatnick & Vande Woude (I966) , adapted for use with cell monolayers, gave more consistent results. The efficiency of extraction ranged from Io -~ to lo -°. Washed newly confluent monolayers in I oz bottles were infected at a multiplicity of approximately Io p.f.u./cell. Three ml. of serum-free medium was added and the bottles incubated in a water bath at 42 + o'o5 °. Pairs of bottles were withdrawn at intervals and one was rapidly frozen for subsequent assay of infectivity and CF antigen. One ml. of 1% (w/v) sodium dodecyl sulphate was added to the other bottle, followed by I ml. 1% (w/v) DEAE dextran and 2 ml. pH 5"o acetate buffer. The mixture was held at + 4 ° for I5 rain. and the sodium dodecyl sulphate was precipitated with an excess of o'I5 M-KC1. The content of each 1 oz bottle was centrifuged at 2,ooo rev./min, for 5 rain. in the cold and dilutions were made from the supernatant fluid directly into phosphate buffered saline. One drop of 1% (w/v) DEAE dextran was added to each 2 ml. of diluent immediately after dilution (Bachrach, I966). o-2 ml. of each dilution was inoculated immediately on to BHK monolayers which had been prewashed with phosphate buffered saline containing 1% (w/v) DEAE dextran. The time allowed for adsorption was I5 min. at room temperature. Plaque counts were made after 24 hr incubation at 37 °. A parallel series of dilutions without DEAE dextran and containing I ~g./ml. pancreatic ribonuclease was prepared and assayed simultaneously as a control.
Complement fixing activity. The complement fixing activity of the samples was measured quantitatively by the method described by Brooksby (I 952), in which antigen is allowed to react with excess antiserum in the presence of increasing amounts of complement.
Recombination experiments. Newly confluent monolayers in I oz bottles were infected in duplicate. The total multiplicity of infection ranged from 2 to 2o p.f.u./cell, and was approximately equated in the self crosses and mixed infections. The period of adsorption was 2o rain. at 37 °. The monolayers were washed with pH 6"4 phosphate buffer for Io rain. at room temperature to destroy unadsorbed virus. The cultures were incubated for 5 hr in a water bath at 37 + o'o5 °, and then rapidly frozen in an ethanol solid CO2 bath.
The frequency of recombination in each cross was expressed as a percentage calculated from the plaque count obtained by assay of the mixed infection at 420 , less the mean plaque count obtained by assay of the selfed crosses at 42°, divided by the plaque count of the mixed infection at 37 ° .
Interferon production. Mutants ts Io, ts I4, ts I5, ts I8, ts 22 and ts 3o were examined to determine whether interferon played any role in temperature sensitivity. Monolayers of BHK C I3 cells were infected at an approximate multiplicity of 5 p.f.u./cell. After 15 min. adsorption at 37 °, the inoculum was removed and the monolayers washed with pH 6"4 phosphate buffer to destroy unadsorbed virus. The infected monolayers were incubated in a water bath at the restrictive temperature and samples of supernatant fluid removed at 2, 4, 6 and 8 hr after infection. A portion of each sample was used to assay infectivity at both permissive and restrictive temperatures. The remainder of each sample was acidified to pH 2.o for 24 hr at 4 °, and after neutralization tested for interferon activity as follows. Duplicate monolayers were exposed to 3 ml. of twofold dilutions of each preparation in Eagle's medium with 1% calf serum for 24 hr at 37 °. One series of monolayers together with untreated controls was infected with a standard challenge dilution of a ts + clone of the same strain and the other with a clone of strain ovl, which belongs to a different immunological type of FMDV. Interferon activity was measured as the dilution causing a 50 % reduction in plaque count. 
Physiological characterization of the ts mutants
Temperature shift experiments, in which replicate cultures were transferred at intervals from the permissive (37 °) to the restrictive (42 °) temperature, indicated that none of these ]7 mutants was defective in steps occurring early in the virus cycle; although minor differences could be observed between different mutants. for mutants ts I and ts 2, which represent the maximum difference observed. Experiments in which the temperature shift was in the reverse direction gave similar but less precise results, on account of the unimpeded replication of revertants. protein synthesis, respectively, and were measured at intervals over a period equivalent to that of a normal single-step growth cycle. In each individual experiment pairs of mutants were compared against a non-mutant clone, and each mutant was examined on two separate occasions. The maximum yields of infective RNA and CF antigen were not reached at the same time after infection when different mutants were compared, e.g. in Fig. 2 the kinetics of infective RNA production of mutants ts 2 and ts 22 were similar, but not those of CF antigen production. The values presented in Table I have been calculated from the maximum yield attained during the course of a single cycle of infection, not from the value at any particular time after infection. This procedure yielded a more consistent result. * The mutants are listed in order of increasing yield of infective RNA. t The total yield was calculated from the plaque count at 37 °. The revertant yield was calculated from the plaque count at 4I '5 °. § The leak yield is the difference between the revertant and the total yield.
The yields of infective RNA and CF antigen presented in Table 1 are given as percentages of the non-mutant clone control value at the restrictive temperature. The leak yield and the revertant frequency were low in most cases and did not account for the observed yields of infective RNA and CF antigen. In all cases the frequency of revertants at the time of infection was less than o.ooI ~. The yields of infective RNA ranged from less than o.31 ~ to 87 ~ of normal, and the yields of CF antigen from I2.6 ~ to 99"6 ~ of normal. None of the mutants was deficient in both infective RNA production and CF antigen production. At zero time no infective RNA was detected.
The mutants did not fall into discrete groups when either characteristic was considered separately. When the ratio of infective RNA to CF antigen production was taken, however, the mutants could be grouped. Mutants ts IO, ts I4, ts i5, ts I8, ts 22, ts 30 and a ts + clone were examined for the ability to induce interferon production by the procedure outlined under Methods. No interference was observed at a 1/4 dilution, which was the lowest dilution examined. Therefore it was concluded that interferon played no role in the temperature sensitivity of these representative ts mutants.
Results of genetic experiments
The ts mutants were crossed in pairs at the permissive temperature and the frequency of the non-mutant class of recombinant estimated from plaque counts at 37 ° and 47"5 ° . Considerable variation was observed in the outcome of repeated crosses of the same pair of ts mutants, consequently it was not feasible to construct a genetic map such as achieved for poliovirus by Cooper (I 968) . Nevertheless the results obtained were consistent with the physiological classification of the mutants. The recombination frequencies observed in 43 of the I36 possible two-factor crosses of these I7 mutants are presented in Table 2 , together with the physiological classification of the mutants involved in each cross. The frequencies are the mean values from duplicate experiments.
The crosses in column I have been scored as positive instances of recombination, whereas those in columns z and 3 have been regarded as crosses in which recombination was not detected. The scores in parentheses indicate an arbitrary decision. Assuming the correctness of these decisions the data can be interpreted as follows. Considering columns i and 2 first, mutants in group B undergo recombination with mutants in groups A and C, but not with other mutants in group B, suggesting that the group B mutants are genetically identical or map at closely related sites. The group C mutants, on the other hand, are genetically heterogenous and fall into a minimum of three subgroups. Mutants ts 7, ts 5, ts I4, ts 16, ts I7 and ts 28 did not recombine when crossed inter se, but did recombine with other group C mutants and with group B mutants. Likewise mutants ts 2, ts 9 and ts 3o form a second subgroup, recombining with group A, B and C mutants. Mutant ts I5 recombined with mutants of both the foregoing C subgroups and of group B, and therefore must constitute a third subgroup.
The crosses in column 3 all involved mutants ts 18, ts 22 and ts 23, and showed little evidence of recombination. These mutants have been excluded from consideration, therefore, on the presumption that they were multiple mutants. Mutants ts I8 and ts 2a indeed were both atypical in forming minute plaques under agarose overlay, whereas all the other mutants and the wild type formed large plaques. Little information is available concerning mutant ts 23, because the results of several crosses were negated by high frequencies of revertants in the controls.
DISCUSSION
The ratio of infective RNA to CF antigen production has provided the basis for a physiological classification of these ts mutants, which was consistent with the results of recombination experiments, provided certain assumptions were made about the singularity of the mutants. These mutants therefore behave as typical conditional lethal On: Tue, 12 Feb 2019 19:57:25 ts mutants of FMDV z~9 mutants, i.e. a single phenotypic characteristic can be used to obtain mutants affecting different steps in the synthesis and assembly of FMDV. There was no evidence, for instance, that temperature sensitivity was mediated in a non-specific manner by interferon.
The temperature shift experiments indicated that all the mutants concerned 'late' functions. Nevertheless mutants ts IO, ts I8 and ts 23 (group A) either produced a non-infectious RNA or no RNA at all, suggesting that these mutants were located in the region of the genome coding for the viral RNA polymerase. Polatnick & Arlinghaus 0967) have shown, however, that virus induced RNA-dependent RNA polymerase activity cannot be demonstrated in vitro much before the onset of virus maturation, consequently this activity can be considered as a late function in the context of the above experiments.
Mutants ts 3, ts ~ I, ts 22 and ts z6 (group B) produce an infective RNA, but relatively less CF antigen. In this case the mutational lesion could involve a part of the genome coding either for a structural component of the virion, or for a factor involved in the synthesis and assembly of the particle. The group C mutants are evidently heterogenous, and the genetic data suggests at least 3 subgroups. Again the defective functions cannot be positively identified, but could involve either a structural protein or factors involved in maturation. A defective structural component might have given rise to an altered electrophoretic mobility, since electrophoretic mutants have been isolated previously following 5-fluorouracil treatment (Pringle, I969) . Mutants ts I, ts 3, ts 9, ts 15, ts 16, ts I8 and ts 22, however, did not differ in electrophoretic properties from a ts + clone, and it was not possible to identify capsid mutants by this method. The recombination findings can be regarded as no more than tentative in view of their incompleteness. In particular no data are available concerning crosses within group A and between groups A and B. The outcome of these recombination experiments has been adversely influenced by variation in host cell sensitivity, making control of multiplicity of infection difficult, by high marker reversion rates, and probably also as a result of aggregation which has been recognised as a complication in a previous experiment (Pringle & Slade, I968) . Analysis of the structure of the genome of FMDV will require greater precision than obtained in these experiments. It is not certain, for instance, whether the mutants making up groups A and B and the 3 subgroups of group C are located in different viral genes, or whether they represent groups of homologous mutants located at different sites within the same gene.
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